搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bombyx mori Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial, partial CSB-YP627063BTT
CSB-EP627063BTT
CSB-BP627063BTT
CSB-MP627063BTT
CSB-EP627063BTT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vampyressa pusilla NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP627064VAAH1
CSB-EP627064VAAH1
CSB-BP627064VAAH1
CSB-MP627064VAAH1
CSB-EP627064VAAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chiroderma villosum NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP627065CBAP1
CSB-EP627065CBAP1
CSB-BP627065CBAP1
CSB-MP627065CBAP1
CSB-EP627065CBAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Uncharacterized protein BNLF2b (BNLF2b) CSB-YP627066EEZ
CSB-EP627066EEZ
CSB-BP627066EEZ
CSB-MP627066EEZ
CSB-EP627066EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 1 (EBNA1), partial CSB-YP627067EEZ
CSB-BP627067EEZ
CSB-MP627067EEZ
CSB-EP627067EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 4 (EBNA4), partial CSB-YP627068EEZ
CSB-EP627068EEZ
CSB-BP627068EEZ
CSB-MP627068EEZ
CSB-EP627068EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Epstein-Barr virus Deneddylase BPLF1 (BPLF1), partial CSB-YP627069EEZ
CSB-EP627069EEZ
CSB-BP627069EEZ
CSB-MP627069EEZ
CSB-EP627069EEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Micromonas pusilla reovirus Uncharacterized protein VP10 (S10) CSB-YP627070MBAA
CSB-EP627070MBAA
CSB-BP627070MBAA
CSB-MP627070MBAA
CSB-EP627070MBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Micromonas pusilla reovirus Uncharacterized protein VP6 (S6), partial CSB-YP627071MBAA
CSB-EP627071MBAA
CSB-BP627071MBAA
CSB-MP627071MBAA
CSB-EP627071MBAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative beta-neurotoxin Td5 CSB-YP627072TOM
CSB-EP627072TOM
CSB-BP627072TOM
CSB-MP627072TOM
CSB-EP627072TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus discrepans Putative beta-neurotoxin Td3 CSB-YP627073TOM
CSB-EP627073TOM
CSB-BP627073TOM
CSB-MP627073TOM
CSB-EP627073TOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila Coproporphyrinogen-III oxidase, aerobic (hemF) CSB-YP627074PAAK
CSB-EP627074PAAK
CSB-BP627074PAAK
CSB-MP627074PAAK
CSB-EP627074PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila ATP synthase subunit c (atpE), partial CSB-YP627075PAAK1
CSB-EP627075PAAK1
CSB-BP627075PAAK1
CSB-MP627075PAAK1
CSB-EP627075PAAK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila ATP synthase gamma chain (atpG) CSB-YP627076PAAK
CSB-EP627076PAAK
CSB-BP627076PAAK
CSB-MP627076PAAK
CSB-EP627076PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila Pyridoxamine kinase (pdxY) CSB-YP627077PAAK
CSB-EP627077PAAK
CSB-BP627077PAAK
CSB-MP627077PAAK
CSB-EP627077PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila Acetylglutamate kinase (argB) CSB-YP627078PAAK
CSB-EP627078PAAK
CSB-BP627078PAAK
CSB-MP627078PAAK
CSB-EP627078PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila Tyrosine recombinase XerC (xerC) CSB-YP627079PAAK
CSB-EP627079PAAK
CSB-BP627079PAAK
CSB-MP627079PAAK
CSB-EP627079PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila RNA pyrophosphohydrolase (rppH) CSB-YP627080PAAK
CSB-EP627080PAAK
CSB-BP627080PAAK
CSB-MP627080PAAK
CSB-EP627080PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP627081PAAK
CSB-EP627081PAAK
CSB-BP627081PAAK
CSB-MP627081PAAK
CSB-EP627081PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas entomophila D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP627082PAAK
CSB-EP627082PAAK
CSB-BP627082PAAK
CSB-MP627082PAAK
CSB-EP627082PAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>